Braden Michael Leonard

Insider Reports History

Entity
Individual
Location
156 S. First Street, Zionsville, IN
Signature
Braden Michael Leonard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Braden Michael Leonard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gemini Therapeutics, Inc. /DE 10%+ Owner Common Stock 5M $338M $67.65 Oct 26, 2022 Holding of BML Investment Partners, L.P.
ASTROTECH Corp 10%+ Owner Common Stock 6.61M $55.1M $8.34 Dec 2, 2022 Holding of BML Investment Partners, L.P.(1)
ASTROTECH Corp 10%+ Owner Common Stock 6.35M $52.9M $8.34 Nov 18, 2022 Holding of BML Investment Partners, L.P.
IMARA Inc. 10%+ Owner Common Stock 1.77M $26.8M $15.14 Jan 4, 2023 Holding of BML Investment Partners, L.P.
Aclaris Therapeutics, Inc. 10%+ Owner Common Stock 14.3M $17.7M $1.24 Aug 5, 2024 Holding of BML Investment Partners, L.P
Gemini Therapeutics, Inc. /DE 10%+ Owner Common Stock 248K $16.7M $67.65 Oct 26, 2022 Direct
Adverum Biotechnologies, Inc. 10%+ Owner Common Stock 2.27M $16.2M $7.15 Jul 30, 2024 Holding of BML Investment Partners, L.P.
Cyteir Therapeutics, Inc. 10%+ Owner Common Stock, par value $0.001 per share 3.65M $10.8M $2.95 Mar 20, 2024 Holding of BML Investment Partners, L.P
AN2 Therapeutics, Inc. 10%+ Owner Common Stock 5.75M $5.98M $1.04 Aug 14, 2024 Holding of BML Investment Partners, L.P.
Satsuma Pharmaceuticals, Inc. 10%+ Owner Common Stock 6.44M $5.86M $0.91 Nov 21, 2022 Holding of BML Investment Partners, L.P.
IMARA Inc. 10%+ Owner Common Stock 230K $3.48M $15.14 Jan 3, 2023 Direct
ASTROTECH Corp 10%+ Owner Common Stock 350K $2.92M $8.34 Dec 2, 2022 Direct
Metacrine, Inc. 10%+ Owner Common Stock 6.16M $2.9M $0.47 Dec 21, 2022 Holding of BML Investment Partners, L.P.
Cyteir Therapeutics, Inc. 10%+ Owner Common Stock, par value $0.001 per share 335K $988K $2.95 Mar 20, 2024 Direct
RETRACTABLE TECHNOLOGIES INC 10%+ Owner Common Stock 689K $847K $1.23 Dec 29, 2022 Holding of BML Investment Partners, L.P.
Adverum Biotechnologies, Inc. 10%+ Owner Common Stock 105K $749K $7.15 Jul 30, 2024 Direct
Tectonic Therapeutic, Inc. Former 10% owner of AVROBIO Common Stock 400K $520K $1.30 Jun 20, 2024 Holding of BML Investment Partners, L.P,
Reneo Pharmaceuticals, Inc. Former 10% owner of RPHM Common Stock 346K $517K $1.50 Oct 7, 2024 Holdings of BML Investment Partners, L.P.
RETRACTABLE TECHNOLOGIES INC 10%+ Owner Common Stock 388K $477K $1.23 Dec 29, 2022 Direct
Talis Biomedical Corp 10%+ Owner Common Stock 249K $369K $1.48 Sep 6, 2024 Holding of BML Investment Partners, L.P.
Metacrine, Inc. 10%+ Owner Common Stock 600K $282K $0.47 Dec 19, 2022 Direct
Reneo Pharmaceuticals, Inc. Former 10% owner of RPHM Common Stock 102K $153K $1.50 Oct 7, 2024 Direct
Satsuma Pharmaceuticals, Inc. 10%+ Owner Common Stock 150K $137K $0.91 Nov 21, 2022 Direct
Tectonic Therapeutic, Inc. Former 10% owner of AVROBIO Common Stock 33.3K $43.3K $1.30 Jun 20, 2024 Direct
RETRACTABLE TECHNOLOGIES INC 10%+ Owner Put Option (obligation to buy) 0 Nov 28, 2022 Holding of BML Investment Partners, L.P.

Insider Reports Filed by Braden Michael Leonard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Oct 7, 2024 2 $0 4 Oct 9, 2024 Former 10% owner of RPHM
RPHM Reneo Pharmaceuticals, Inc. Sep 24, 2024 2 $145K 4 Sep 26, 2024 10%+ Owner
RPHM Reneo Pharmaceuticals, Inc. Sep 17, 2024 2 $76.2K 4 Sep 19, 2024 10%+ Owner
RPHM Reneo Pharmaceuticals, Inc. Sep 12, 2024 3 $484K 4 Sep 16, 2024 10%+ Owner
TLIS Talis Biomedical Corp Sep 5, 2024 2 $44.2K 4 Sep 9, 2024 10%+ Owner
TLIS Talis Biomedical Corp Sep 3, 2024 1 $2K 4 Sep 5, 2024 10%+ Owner
TLIS Talis Biomedical Corp Aug 30, 2024 1 $642 4 Sep 4, 2024 10%+ Owner
TLIS Talis Biomedical Corp Aug 28, 2024 2 $56.1K 4 Aug 28, 2024 10%+ Owner
TLIS Talis Biomedical Corp Aug 14, 2024 0 $0 3 Aug 14, 2024 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 14, 2024 1 $1.56M 4 Aug 14, 2024 10%+ Owner
RPHM Reneo Pharmaceuticals, Inc. Aug 13, 2024 2 $381K 4 Aug 14, 2024 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 9, 2024 0 $0 3 Aug 12, 2024 10%+ Owner
ACRS Aclaris Therapeutics, Inc. Aug 2, 2024 2 $473K 4 Aug 5, 2024 10%+ Owner
ADVM Adverum Biotechnologies, Inc. Jul 30, 2024 1 $613K 4 Jul 31, 2024 10%+ Owner
ACRS Aclaris Therapeutics, Inc. Jul 30, 2024 2 $359K 4 Jul 31, 2024 10%+ Owner
ACRS Aclaris Therapeutics, Inc. Jul 18, 2024 3 $202K 4 Jul 22, 2024 10%+ Owner
ADVM Adverum Biotechnologies, Inc. Jul 18, 2024 2 $1.79M 4 Jul 18, 2024 10%+ Owner
ADVM Adverum Biotechnologies, Inc. Jul 17, 2024 0 $0 3 Jul 18, 2024 10%+ Owner
ACRS Aclaris Therapeutics, Inc. Jul 2, 2024 3 $406K 4 Jul 5, 2024 10%+ Owner
ACRS Aclaris Therapeutics, Inc. Jun 27, 2024 4 $1.74M 4 Jul 1, 2024 10%+ Owner
TECX Tectonic Therapeutic, Inc. Jun 20, 2024 2 $0 4 Jun 25, 2024 Former 10% owner of AVROBIO
ACRS Aclaris Therapeutics, Inc. Jun 14, 2024 3 $628K 4 Jun 18, 2024 10%+ Owner
ACRS Aclaris Therapeutics, Inc. Jun 11, 2024 4 $1.78M 4 Jun 13, 2024 10%+ Owner
RPHM Reneo Pharmaceuticals, Inc. May 14, 2024 2 $640K 4 May 16, 2024 10%+ Owner
RPHM Reneo Pharmaceuticals, Inc. May 14, 2024 0 $0 3 May 16, 2024 10%+ Owner
AVRO AVROBIO, Inc. May 13, 2024 3 $971K 4 May 15, 2024 10%+ Owner
AVRO AVROBIO, Inc. May 13, 2024 0 $0 3/A May 15, 2024 10%+ Owner
AVRO AVROBIO, Inc. May 13, 2024 0 $0 3 May 15, 2024 10%+ Owner
CYT Cyteir Therapeutics, Inc. Mar 20, 2024 1 $503K 4 Mar 25, 2024 10%+ Owner
CYT Cyteir Therapeutics, Inc. Mar 19, 2024 1 $342K 4 Mar 19, 2024 10%+ Owner
CYT Cyteir Therapeutics, Inc. Mar 15, 2024 0 $0 3 Mar 19, 2024 10%+ Owner
ACRS Aclaris Therapeutics, Inc. Feb 7, 2024 0 $0 3 Feb 8, 2024 10%+ Owner
ELVN IMARA Inc. Jan 3, 2023 1 -$5M 4/A Jan 5, 2023 10%+ Owner
ELVN IMARA Inc. Dec 30, 2022 1 -$80.8K 4 Dec 30, 2022 10%+ Owner
RVP RETRACTABLE TECHNOLOGIES INC Dec 29, 2022 1 -$4.8M 4 Dec 29, 2022 10%+ Owner
ELVN IMARA Inc. Dec 28, 2022 2 -$80.8K 4 Dec 29, 2022 10%+ Owner
ELVN IMARA Inc. Dec 22, 2022 2 -$203K 4 Dec 27, 2022 10%+ Owner
MTCR Metacrine, Inc. Dec 19, 2022 3 $108K 4 Dec 21, 2022 10%+ Owner
ASTC ASTROTECH Corp Dec 2, 2022 1 $65.6K 4 Dec 2, 2022 10%+ Owner
RVP RETRACTABLE TECHNOLOGIES INC Nov 28, 2022 2 -$506K 4 Nov 30, 2022 10%+ Owner
ASTC ASTROTECH Corp Nov 23, 2022 1 $24.7K 4 Nov 25, 2022 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 21, 2022 1 $107K 4 Nov 23, 2022 10%+ Owner
ASTC ASTROTECH Corp Nov 16, 2022 3 $145K 4 Nov 18, 2022 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 14, 2022 3 $4.39M 4 Nov 16, 2022 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 14, 2022 0 $0 3 Nov 16, 2022 10%+ Owner
MTCR Metacrine, Inc. Nov 7, 2022 3 $68.1K 4 Nov 9, 2022 10%+ Owner
MTCR Metacrine, Inc. Oct 27, 2022 2 $317K 4 Oct 31, 2022 10%+ Owner
IRON Gemini Therapeutics, Inc. /DE Oct 26, 2022 1 -$47K 4 Oct 27, 2022 10%+ Owner
MTCR Metacrine, Inc. Oct 24, 2022 3 $443K 4 Oct 26, 2022 10%+ Owner
MTCR Metacrine, Inc. Oct 24, 2022 0 $0 3 Oct 26, 2022 10%+ Owner
ASTC ASTROTECH Corp Oct 14, 2022 2 $81.8K 4 Oct 18, 2022 10%+ Owner
ASTC ASTROTECH Corp Sep 23, 2022 3 $157K 4 Sep 27, 2022 10%+ Owner
ASTC ASTROTECH Corp Sep 1, 2022 2 $117K 4 Sep 7, 2022 10%+ Owner
ASTC ASTROTECH Corp Aug 24, 2022 0 $0 3 Aug 25, 2022 10%+ Owner
ASTC ASTROTECH Corp Aug 23, 2022 2 $219K 4 Aug 25, 2022 10%+ Owner
ELVN IMARA Inc. Jun 16, 2022 1 $92.2K 4 Jun 21, 2022 10%+ Owner
ELVN IMARA Inc. Jun 3, 2022 2 $38K 4 Jun 7, 2022 10%+ Owner
RVP RETRACTABLE TECHNOLOGIES INC May 23, 2022 2 $253K 4 May 25, 2022 10%+ Owner
RVP RETRACTABLE TECHNOLOGIES INC May 17, 2022 3 $535K 4 May 19, 2022 10%+ Owner
ELVN IMARA Inc. May 16, 2022 2 $50.4K 4 May 18, 2022 10%+ Owner
RVP RETRACTABLE TECHNOLOGIES INC May 12, 2022 3 $554K 4 May 16, 2022 10%+ Owner
RVP RETRACTABLE TECHNOLOGIES INC May 9, 2022 3 $281K 4 May 11, 2022 10%+ Owner
RVP RETRACTABLE TECHNOLOGIES INC Apr 28, 2022 3 $1.6M 4 May 2, 2022 10%+ Owner
RVP RETRACTABLE TECHNOLOGIES INC Apr 28, 2022 0 $0 3 May 2, 2022 10%+ Owner
ELVN IMARA Inc. Apr 21, 2022 2 $784K 4 Apr 25, 2022 10%+ Owner
ELVN IMARA Inc. Apr 21, 2022 0 $0 3 Apr 25, 2022 10%+ Owner
IRON Gemini Therapeutics, Inc. /DE Apr 11, 2022 4 $1.34M 4 Apr 13, 2022 10%+ Owner
IRON Gemini Therapeutics, Inc. /DE Apr 11, 2022 0 $0 3 Apr 13, 2022 10%+ Owner